| A majority of low (1-10%) ER positive breast cancers behave like hormone receptor negative tumors JS Prabhu, A Korlimarla, K Desai, A Alexander, R Raghavan, ... Journal of Cancer 5 (2), 156, 2014 | 126 | 2014 |
| The impact of breast cancer on the patient and the family in Indian perspective A Alexander, R Kaluve, JS Prabhu, A Korlimarla, BS Srinath, S Manjunath, ... Indian journal of palliative care 25 (1), 66, 2019 | 85 | 2019 |
| The epigenetic silencing of the estrogen receptor (ER) by hypermethylation of the ESR1 promoter is seen predominantly in triple-negative breast cancers in Indian women JS Prabhu, K Wahi, A Korlimarla, M Correa, S Manjunath, N Raman, ... Tumor Biology 33, 315-323, 2012 | 41 | 2012 |
| High expression of integrin β6 in association with the Rho–Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers K Desai, MG Nair, JS Prabhu, A Vinod, A Korlimarla, S Rajarajan, ... Cancer medicine 5 (8), 2000-2011, 2016 | 40 | 2016 |
| Cystic neutrophilic granulomatous mastitis: a clinicopathological study with 16s rRNA sequencing for the detection of corynebacteria in formalin-fixed paraffin-embedded tissue MA Naik, A Korlimarla, ST Shetty, AM Fernandes, SA Pai International journal of surgical pathology 28 (4), 371-381, 2020 | 34 | 2020 |
| miR‐18a activates Wnt pathway in ER‐positive breast cancer and is associated with poor prognosis MG Nair, JS Prabhu, A Korlimarla, S Rajarajan, H PS, R Kaul, ... Cancer Medicine 9 (15), 5587-5597, 2020 | 26 | 2020 |
| Separate quality-control measures are necessary for estimation of RNA and methylated DNA from formalin-fixed, paraffin-embedded specimens by quantitative PCR A Korlimarla, JS Prabhu, CE Anupama, J Remacle, K Wahi, TS Sridhar The Journal of molecular diagnostics 16 (2), 253-260, 2014 | 26 | 2014 |
| Identification of a non-canonical nuclear localization signal (NLS) in BRCA1 that could mediate nuclear localization of splice variants lacking the classical NLS A Korlimarla, L Bhandary, JS Prabhu, H Shankar, H Sankaranarayanan, ... Cellular & Molecular Biology Letters 18, 284-296, 2013 | 20 | 2013 |
| HR+ HER2− breast cancers with growth factor receptor–mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells K Desai, R Aiyappa, JS Prabhu, MG Nair, PV Lawrence, A Korlimarla, ... Tumor Biology 39 (3), 1010428317695028, 2017 | 16 | 2017 |
| Identification of BRCA1 deficiency using multi-analyte estimation of BRCA1 and its repressors in FFPE tumor samples from patients with triple negative breast cancer A Korlimarla, JS Prabhu, J Remacle, S Rajarajan, U Raja, A CE, ... PLoS One 11 (4), e0153113, 2016 | 16 | 2016 |
| Gene-specific methylation: potential markers for colorectal cancer JS Prabhu, A Korlimarla, A Banerjee, S Wani, K Payal, R Sahoo The International journal of biological markers 24 (1), 57-62, 2009 | 16 | 2009 |
| Prenatal epigenetic factors are predisposing for neurodevelopmental disorders—Considering placenta as a model S Durbagula, A Korlimarla, G Ravikumar, S Valiya Parambath, SM Kaku, ... Birth Defects Research 114 (20), 1324-1342, 2022 | 11 | 2022 |
| Pre-menopausal women with breast cancers having high AR/ER ratios in the context of higher circulating testosterone tend to have poorer outcomes S Rajarajan, A Korlimarla, A Alexander, CE Anupama, R Ramesh, ... Frontiers in Endocrinology 12, 679756, 2021 | 11 | 2021 |
| Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer R Bajaj, R Tripathi, TS Sridhar, A Korlimarla, KD Choudhury, ... PLoS One 15 (11), e0242190, 2020 | 10 | 2020 |
| Relationship between molecular markers and treatment response in a retrospective cohort of Indian patients with primary carcinoma of the larynx R Sahoo, V Chittibabu, G Patil, S Rao, S Thakur, G Dhondalay, ... Oral oncology 45 (12), e216-e221, 2009 | 10 | 2009 |
| Dissecting the biological heterogeneity within hormone receptor positive HER2 negative breast cancer by gene expression markers identifies indolent tumors within late stage disease JS Prabhu, A Korlimarla, CE Anupama, A Alexander, R Raghavan, R Kaul, ... Translational Oncology 10 (4), 699-706, 2017 | 9 | 2017 |
| Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers A Korlimarla, PS Hari, J Prabhu, C Ragulan, Y Patil, VP Snijesh, K Desai, ... Translational Oncology 25, 101511, 2022 | 7 | 2022 |
| Abstract P4-10-12: Treatment decision making, and strategies for coping with financial stress in Indian women diagnosed with breast cancer and their families A Alexander, R Kaluve, JS Prabhu, A Korlimarla, S BS, S Manjunath, ... Cancer Research 78 (4_Supplement), P4-10-12-P4-10-12, 2018 | 5 | 2018 |
| Abstract PS6-55: The prognostic utility of AR/ER ratio in young women with breast cancer JS Prabhu, A Korlimarla, S Rajarajan, A Alexander, C Anupama, ... Cancer research 81 (4 Suppl), PS6-55, 2021 | 3 | 2021 |
| Alternate Epigenetic Mechanism for the Repression of BRCA1 in Sporadic Breast Cancers Mediated by MIR182 A Korlimarla, JS Prabhu, J Remacle, U Raja, BS Srinath, TS Sridhar Annals of Oncology 25, i8, 2014 | 3 | 2014 |
